Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceMen's health

Prostate Formulas

The typical prostate blend is built around saw palmetto — the one ingredient a large, well-run trial showed does nothing, even at triple the standard dose. Beta-sitosterol and pygeum have better data, but they are usually present at token amounts, and the finished formulas have almost never been tested.

What the science says

  • Saw palmetto, the lead ingredient, does not beat placebo Strong evidence

    The CAMUS trial randomised 369 men to escalating saw palmetto doses up to 960 mg/day for 72 weeks and found no difference from placebo in AUA symptom index (about -2.2 vs -3.0 points, favouring placebo numerically). The Cochrane review of 32 studies in 5666 men reached the same verdict: no improvement in urinary symptoms or flow rate versus placebo, including at double and triple doses.

  • Other ingredients have modest support, but not at label doses Limited evidence

    Beta-sitosterol (60-130 mg/day) and pygeum (75-200 mg/day of standardised extract) do show symptom benefit in pooled trials, but blends often list them as part of a proprietary matrix at unstated or sub-therapeutic amounts. A formula listing ten ingredients in a 500 mg blend cannot be delivering the studied dose of more than one or two of them.

  • Prostate formulas prevent prostate cancer Limited evidence

    No supplement has been shown to prevent prostate cancer, and two common formula ingredients performed badly when properly tested: in a large randomised prevention trial, vitamin E supplementation was associated with a significantly increased incidence of prostate cancer (roughly 17% relative increase) and selenium provided no benefit. Lycopene and zinc likewise lack prevention trial support at supplement doses.

  • They can substitute for medical evaluation Limited evidence

    None of these products reduce prostate size or PSA, so they neither treat BPH's progression nor mask cancer — but relying on them can delay diagnosis. Alpha-blockers and 5-alpha-reductase inhibitors have large, consistent trial evidence for symptoms and for preventing retention and surgery, and no blend has been compared against them.

Dosage & safety

Studied doseLabel doses are typically saw palmetto 320 mg, beta-sitosterol 10-50 mg, pygeum 25-100 mg, nettle root 100-250 mg, plus lycopene, zinc and selenium. Studied doses are saw palmetto 320 mg/day (which failed anyway), beta-sitosterol 60-130 mg/day, pygeum 75-200 mg/day of standardised extract, rye pollen extract two tablets three times daily. If any single ingredient is wanted, buy it alone at the trial dose rather than in a blend.
SafetyIndividually these ingredients are mild — GI upset and, occasionally, reduced libido or ejaculatory changes with saw palmetto. The category risks are additive and regulatory. Many formulas include selenium and vitamin E, and stacking them with a multivitamin can push selenium past the 400 mcg/day upper limit (causing hair and nail loss, GI symptoms, neuropathy) while vitamin E supplementation has an unfavourable prostate cancer signal. Zinc above 40 mg/day long term impairs copper status. Saw palmetto has isolated reports of bleeding and of liver and pancreatic injury. Crucially, no ingredient here reliably lowers PSA, so PSA-based screening remains interpretable — but urinary retention, blood in the urine, bone pain, or a rising PSA require urology, not a supplement. Men already on tamsulosin, finasteride, or dutasteride should not swap them for a formula without discussing it.

Scientific references

Where to buy

Snap Supplements, Prostate Health, 90 Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Men's health